Clin2
NCT06426836Possibly a fitRecruiting

Better antibiotic dosing for children on ECMO

PharmacokineticsAmoxicillin-clavulanatePiperacillin-tazobactamMeropenemCefazolinTeicoplaninVancomycinCiprofloxacin

Treatments studied

Amoxicillin-clavulanatePiperacillin-tazobactamMeropenemCefazolinVancomycinCiprofloxacinAmikacin

Part of Infections clinical trials.

This trial studies how to give the right dose of common antibiotics to children on ECMO (a heart-lung bypass machine). The goal is to help doctors choose the best dose to fight infections while keeping the child safe.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
Up to 15 years
Study type
Interventional

Who can take part

  • Your child must be in the pediatric or cardiac intensive care unit (ICU).
  • Your child must weigh at least 1.8 kg and be under 15 years old.
  • Your child must be on ECMO (a machine that helps the heart and lungs).
  • Your child must be receiving one of the listed antibiotics through an IV line.
  • Doctors must be able to draw blood samples from a separate line (not the one giving the antibiotic).
  • There must be no known allergy to certain antibiotics like penicillin or ciprofloxacin.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT02456974Recruiting
Testing how antibiotics are dosed in children’s intensive care

This study looks at whether giving common antibiotics in certain dose schedules (either through a drip over time or continuously) is done in a way that fits pediatric intensive care needs. It may help improve antibiotic treatment for children who are very sick and need antibiotics.

Ghent
NCT06929702Recruiting· Phase 4
Precision dosing of antibiotics for critically ill children

This trial tests a personalized dosing approach for certain antibiotics (amoxicillin-clavulanic acid, piperacillin-tazobactam, and meropenem) in hospitalized children with serious infections. The goal is to adjust the dose based on blood tests to make sure each child gets the right amount of medicine.

Ghent
NCT07822243Recruiting
Antibiotic penetration in critically ill children

This study looks at why some antibiotics given through a vein may reach infections differently in very sick children. It aims to make sure medicines are given in the best way to help children in the intensive care unit recover.

Ghent
NCT06338345Not yet recruiting
Antibiotic dosing study for patients on heart-lung support

This study looks at how certain antibiotics behave in your body when you are on VA-ECMO. The goal is to find the right dose to treat your infection effectively and safely.

Clermont-Ferrand
NCT06602557Recruiting· Phase 2
Inhaled antibiotic for lung infection during ECMO support

This trial tests whether adding an inhaled antibiotic (amikacin) to standard IV antibiotics can better treat a serious lung infection (pneumonia caused by Gram-negative bacteria) in patients on a heart-lung machine (ECMO) and a breathing tube. If you or your loved one is on ECMO and has this type of pneumonia, this study may offer a new treatment approach.

Paris
NCT06319677Not yet recruiting
Anti-infection drug dosing in critically ill patients on ECMO

This study looks at how anti-infection drugs work in critically ill patients who are on ECMO, a machine that helps the heart and lungs. The goal is to find the right doses so the drugs work better and are safer for people in this condition.

Changsha, Hunan

Hear when a new Amoxicillin-clavulanate trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.